申请人:Ono Pharmaceutical Co., Ltd.
公开号:US06235780B1
公开(公告)日:2001-05-22
(wherein R1 is OH etc.; X is Cl, F; R2 is H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl which may be substituted; n is 0-4.), non-toxic salts thereof or cyclodextrin clathrates thereof can strongly bind on EP2 subtype receptor. Therefore, they are useful for the prevention and/or treatment of immunological diseases (autoimmune diseases, post-transplantation graft rejection etc.), asthma, abnormal bone formation, neuronal cell death, hepatopathy, abortion, premature birth or retina neuropathy (e.g. glaucoma) etc.
其中R1为OH等;X为Cl,F;R2为H,C1-8烷基,C2-8烯基,C2-8炔基,可能被取代;n为0-4。其非毒性盐或环糊精包合物能够强烈结合EP2亚型受体。因此,它们对于预防和/或治疗免疫性疾病(自身免疫疾病,移植后移植物排斥等),哮喘,异常骨骼形成,神经细胞死亡,肝病,流产,早产或视网膜神经病变(如青光眼)等是有用的。